搜索
Search
这是描述信息

Sustainable Development

/
/
ESG Rating And Honors

ESG Rating And Honors

Description:
Description:
Information

ESG Rating And Honors

  • July 2024                    Included in the "Sustainability Yearbook 2024 (China Edition)" by S&P Global and recognized as Industry Mover
  • July 2024                    2024 Yinghua Awards for Chinese Listed Companies: Hong Kong Stock ESG Value Award
  • June 2024                    Wind ESG Rating: AA (Ranked first among domestic pharmaceutical peers as of now)
  • February 2024             CDP Climate Change Questionnaire: B
  • February 2024             Included in the "Sustainability Yearbook 2024" by S&P Global and recognized as Industry Mover
  • January 2024              Included in 2023 Easy-board ESG+8 Top 100 List
  • January 2024              Best ESG Award (Roadshow China & Excellence IR)
  • December 2023          The Sina Finance China ESG "Golden Awards" 2023 Excellent Enterprise for Environmental Responsibility
  • December 2023          The Sina Finance 2023 Pharmaceutical Industry Golden Kirin Award - the Most Socially Responsible Pharmaceutical Company
  • December 2023          2023 TOP 50 ESG Listed Companies in China’s Non-Financial Industry (China Corporate Governance Experts 50 Forum)
  • December 2023          Top 100 Wind Chinese Listed Companies in Best ESG Practice in 2023
  • November 2023          S&P Global ESG Score: 65 (Ranked among the top 5% of global participating pharmaceutical companies)
  • October 2023              CNI ESG Ratings: AAA (Ranked first among domestic pharmaceutical industry)
  • October 2023              The Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness in 2023 (Mid-cap Stocks)
  • August 2023                Top1 of CSR Survey Score of Pharmaceutical Enterprises of Southern Weekly in 2022
  • August 2023                CSI ESG Rating: AAA
  • July 2023                    MSCI ESG Ratings: AAA (The first and only Chinese company in the global pharmaceutical industry to receive the highest MSCI ESG AAA                                                rating)
  • May 2023                    Wind ESG Rating: AA (Ranked first among domestic pharmaceutical peers as at June 2024)
  • May 2023                    5th New Fortune Best Listed Company — Best ESG Practice Award
  • December 2022          CDP Climate Change Questionnaire: B-
  • December 2022          The Reputation List of China Listed Companies for 2022 — Most Socially Responsible Listed Company
  • December 2022          6th China IR Annual Awards — Best ESG Award
  • November 2022          S&P Global CSA Score: 42
  • November 2022         Top 1 of the Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness in 2022
  • October 2022             Top 10 Wind Chinese Hong Kong-listed Companies in ESG Ratings in 2022 — Healthcare Industry
  • September 2022        Top 10 Wind Chinese A-shares Listed Companies in ESG Ratings in 2022 — Healthcare Industry
  • March 2022                New Fortune — Best ESG Information Disclosure Award

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China    Tel: 0756-8135888    

©2021 Livzon  粤ICP备05025993号  Support:300.cn

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China  

©2021 Livzon   粤ICP备05025993号  

 Support:300.cn